CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 105 filers reported holding CYTEK BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $95,161 | +915.9% | 17,054 | +1121.6% | 0.00% | – |
| Q1 2024 | $9,367 | -97.2% | 1,396 | -96.2% | 0.00% | -100.0% |
| Q4 2023 | $330,928 | +931.7% | 36,286 | +524.4% | 0.00% | +300.0% |
| Q3 2023 | $32,077 | +8.9% | 5,811 | +68.5% | 0.00% | 0.0% |
| Q2 2023 | $29,455 | +26922.9% | 3,449 | -70.8% | 0.00% | -66.7% |
| Q1 2023 | $109 | -12.8% | 11,822 | -4.1% | 0.00% | -40.0% |
| Q4 2022 | $125 | -99.9% | 12,326 | +49.5% | 0.01% | +150.0% |
| Q3 2022 | $121,000 | +195.1% | 8,244 | +114.1% | 0.00% | +100.0% |
| Q2 2022 | $41,000 | +105.0% | 3,851 | +104.3% | 0.00% | – |
| Q1 2022 | $20,000 | -13.0% | 1,885 | +30.1% | 0.00% | – |
| Q4 2021 | $23,000 | +109.1% | 1,449 | +184.7% | 0.00% | – |
| Q3 2021 | $11,000 | – | 509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $30,912,000 | 12.48% |
| Miura Global Management | 820,000 | $12,070,000 | 7.24% |
| RA Capital Management | 13,381,054 | $196,969,000 | 4.20% |
| HHLR ADVISORS, LTD. | 8,757,030 | $128,903,000 | 3.39% |
| Brown Capital Management | 4,406,461 | $64,863,000 | 0.91% |
| Perceptive Advisors | 1,289,534 | $18,982,000 | 0.55% |
| Hillsdale Investment Management Inc. | 344,529 | $5,072,000 | 0.46% |
| PURA VIDA INVESTMENTS, LLC | 527,164 | $7,760,000 | 0.45% |
| Parkwood LLC | 42,336 | $623,000 | 0.09% |
| PDT Partners, LLC | 31,436 | $463,000 | 0.07% |